Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Chun, Tae-Wook, Carruth, Lucy, Finzi, Diana, Shen, Xuefei, DiGiuseppe, Joseph A., Taylor, Harry, Hermankova, Monika, Chadwick, Karen +7 more·1997·Nature
DOI 10.1038/387183a0

Cited by (1,000)

Items 701–800 of 1,000

  1. Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation
    Maxime Junior Jean, Tsuyoshi Hayashi, Huachao Huang, Justin W Brennan, Sydney Simpson, Andrei A. Purmal, Katerina V. Gurova, Michael C. Keefer, James J. Kobie, Netty G. Santoso et al. · 2017 · Frontiers in Microbiology
  2. CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
    Genevieve Elizabeth Martin, Matthew J. Pace, John Patrick Thornhill, Chansavath Phetsouphanh, Jodi Meyerowitz, Morgane Gossez, Emily Hopkins, Helen Brown, Nicola Robinson, Natalia J. Olejniczak et al. · 2018 · Frontiers in Immunology
  3. Hematopoietic Stem and Progenitor Cells Are a Distinct HIV Reservoir that Contributes to Persistent Viremia in Suppressed Patients
    Thomas D. Zaikos, Valeri H. Terry, Nadia T. Sebastian, Jay Lubow, Mark M. Painter, Maria Virgilio, Andrew J. Neevel, Frances Taschuk, Adewunmi Onafuwa-Nuga, Lucy A. McNamara et al. · 2018 · Cell Reports
  4. Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection
    Chuen‐Yen Lau, Matthew A. Adan, Frank M. Maldarelli · 2021 · Viruses
  5. Inhibition of Replication of Reactivated Human Immunodeficiency Virus Type 1 (HIV-1) in Latently Infected U1 Cells Transduced with an HIV-1 Long Terminal Repeat-Driven PKR cDNA Construct
    Nicholas F. Muto, Camille Martinand‐Mari, Martin E. Adelson, Robert J. Suhadolnik · 1999 · Journal of Virology
  6. SIVagm genetic and biological features associated with replication
    Michaela C. Müller-Trutwin · 2003 · Frontiers in bioscience
  7. O-Linked N -Acetylglucosaminylation of Sp1 Inhibits the Human Immunodeficiency Virus Type 1 Promoter
    Ramona Jochmann, Mathias Thurau, Susan Jung, Christian Hofmann, Elisabeth Naschberger, Elisabeth Kremmer, Thomas Harrer, Matthew Miller, Niels Schaft, Michael Stürzl · 2009 · Journal of Virology
  8. Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistence
    Roger J. Pomerantz · 2001 · AIDS
  9. Short Communication: Expression of P-Glycoprotein and Multidrug Resistance-Associated Protein in Healthy Volunteers and HIV-Infected Patients
    E. Rhiannon Meaden, Patrick G. Hoggard, B. Maher, Saye Khoo, David J. Back · 2001 · AIDS Research and Human Retroviruses
  10. Randomized, Open-Label Study of the Impact of Two Doses of Subcutaneous Recombinant Interleukin-2 on Viral Burden in Patients With HIV-1 Infection and CD4+ Cell Counts of ≥300/mm3: CPCRA 059
    Donald I. Abrams, Judith D. Bebchuk, Eileen T. Denning, Richard T. Davey, Lawrence M. Fox, Henry Clifford Lane, James H. Sampson, Rita Verheggen, Douglas Zeh, Norman P. Markowitz · 2002 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  11. Treating AIDS Dementia
    Stuart A. Lipton · 1997 · Science
  12. Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes
    Caroline Dufour, Corentin Richard, Marion Pardons, Marta Massanella, Antoine Ackaoui, Ben Murrell, Bertrand Routy, Réjean Thomas, Jean‐Pierre Routy, Rémi Fromentin et al. · 2023 · Nature Communications
  13. Recent trends in HIV-1 drug resistance
    Janet D'Angelo Siliciano, Robert F. Siliciano · 2013 · Current Opinion in Virology
  14. Regulation of HIV-1 Latency by Chromatin Structure and Nuclear Architecture
    Marina Lušić, Mauro Giacca · 2014 · Journal of Molecular Biology
  15. Barriers to a cure for HIV in women
    Sara Gianella, Athe M. N. Tsibris, Elizabeth Barr, Catherine C. Godfrey · 2016 · Journal of the International AIDS Society
  16. HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective
    Loredana Sarmati, Gabriella d’Ettorre, Saverio Giuseppe Parisi, Massimo Andreoni · 2015 · Current HIV Research
  17. Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection
    Priyanka Uprety, Kunjal Patel, Brad Karalius, Carrie Ziemniak, Ya Hui Chen, Sean S. Brummel, Suzanne M. Siminski, Russell B. Van Dyke, George R. Seage, Deborah Persaud et al. · 2017 · Clinical Infectious Diseases
  18. CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency
    Gilles Darcis, Neeltje A. Kootstra, Berend Hooibrink, Thijs van Montfort, Irma Maurer, Kevin Groen, Suzanne Jurriaans, Margreet E. Bakker, Carine M. Van Lint, Ben Berkhout et al. · 2020 · Cell Reports
  19. Picomolar Dichotomous Activity of Gnidimacrin Against HIV-1
    Li Huang, Phong Ho, Jie Yu, Lei Zhu, Kuo‐Hsiung Lee, Chin‐Ho Chen · 2011 · PLoS ONE
  20. Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes
    Richard D. Sloan, Daniel Aaron Donahue, Björn D. Kuhl, Tamara Bar-Magen, Mark A. Wainberg · 2010 · Retrovirology
  21. The importance of virus‐associated host ICAM‐1 in human immunodeficiency virus type 1 dissemination depends on the cellular context
    Salim Bounou, Jean-François Giguère, Réjean Cantin, Caroline Gilbert, Michaël Imbeault, Genevieve Elizabeth Martin, Michel J. Tremblay · 2004 · The FASEB Journal
  22. Dynamics of Naive and Memory CD4+ T Lymphocytes in HIV-1 Disease Progression
    Seema H. Bajaria, Glenn F. Webb, Miles W. Cloyd, Denise E. Kirschner · 2002 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  23. Enhancement of HIV Type 1 Antigen-Specific CD4 + T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen
    Vernon C. Maino, Maria A. Suni, Susan B. Wormsley, Dennis J. Carlo, Mark R. Wallace, Ronald B. Moss · 2000 · AIDS Research and Human Retroviruses
  24. Intracellular expression of Tat alters mitochondrial functions in T cells: a potential mechanism to understand mitochondrial damage during HIV-1 replication
    Sara Rodríguez-Mora, Elena Mateos, María Morán, Miguel Angel Martín, Juan Antonio López, Enrique Calvo, María Carmen Terrón, Daniel Luque, Delphine M. Muriaux, José Alcamı́ et al. · 2015 · Retrovirology
  25. Therapeutic DNA Vaccine Induces Broad T Cell Responses in the Gut and Sustained Protection from Viral Rebound and AIDS in SIV-Infected Rhesus Macaques
    DEBORAH HEYDENBURG FULLER, Premeela A. Rajakumar, Jenny W. Che, Amithi Narendran, Julia Nyaundi, Heather Michael, Eric J. Yager, Cristy Stagnar, Brendon Wahlberg, Rachel Taber et al. · 2012 · PLoS ONE
  26. Deep Sequencing of HIV: Clinical and Research Applications
    Shiven Chabria, Shaili Gupta, Michael J. Kozal · 2014 · Annual Review of Genomics and Human Genetics
  27. Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells
    John K. Bui, Elias Konstantine Halvas, Elizabeth Fyne, Michele D. Sobolewski, Dianna L. Koontz, Wei Shao, Brian T. Luke, Feiyu F. Hong, Mary F. Kearney, John W. Mellors · 2017 · PLoS Pathogens
  28. Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS
    Z Huang, Asahi Tomitaka, Andrea Raymond, Madhavan Nair · 2017 · Gene Therapy
  29. Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence
    Javier Martínez‐Picado, Ryan Zurakowski, Maria José Buzón, Mario Stevenson · 2018 · Retrovirology
  30. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals
    Elizabeth R. Wonderlich, Krupa Subramanian, Bryan D. Cox, Ann P. Wiegand, Carol Lackman-Smith, Michael J. Bale, Mars Stone, Rebecca Hoh, Mary F. Kearney, Frank M. Maldarelli et al. · 2019 · PLoS Pathogens
  31. EVOLUTION OF INTRAHOST HIV - 1 GENETIC DIVERSITY DURING CHRONIC INFECTION
    Daniel Shriner, Yi Liu, David C. Nickle, James I. Mullins · 2006 · Evolution
  32. Hexamethylbisacetamide Remodels the Human Immunodeficiency Virus Type 1 (HIV-1) Promoter and Induces Tat-Independent HIV-1 Expression but Blunts Cell Activation
    Vladimir I. Klichko, Nancy M. Archin, Rupinderjeet Kaur, Ginger K. Lehrman, David M. Margolis · 2006 · Journal of Virology
  33. Molecular mechanisms of HIV-1 proviral latency
    Dwayne A. Bisgrove, Mary K. Lewinski, Frederic D. Bushman, Eric M. Verdin · 2005 · Expert Review of Anti-infective Therapy
  34. In patients on prolonged HAART, a significant pool of HIV infected CD4 T cells are HIV-specific
    Audrey Demoustier, Brigitte Gubler, Olivier Lambotte, Marie-Ghislaine de Goër de Herve, Christine Wallon, Cécile Goujard, Jean‐François Delfraissy, Yassine Taoufik · 2002 · AIDS
  35. HIV Controllers With Different Viral Load Cutoff Levels Have Distinct Virologic and Immunologic Profiles
    Fernanda Heloise Côrtes, Caroline Passaes, Gonzalo Bello, Sylvia Lopes Maia Teixeira, Carla Vorsatz, Dunja Z. Babič, Mark E. Sharkey, Beatriz Gilda Jegerhorn Grinsztejn, Valdilea Gonçalves Veloso, Mario Stevenson et al. · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  36. Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors
    Guillaume Mousseau, Susana T. Valente · 2012 · Biology
  37. Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels
    William J. Hey-Cunningham, John M. Murray, Ven Natarajan, Janaki Amin, Cecilia L. Moore, Sean Emery, David A. Cooper, John Zaunders, Anthony Dominic Kelleher, Kersten K. Koelsch · 2015 · AIDS
  38. The immunological synapse: the gateway to the HIV reservoir
    Deanna A. Kulpa, Jessica H. Brehm, Rémi Fromentin, Anthony B. Cooper, Colleen Cooper, Jeffrey D. Ahlers, Nicolas Chomont, Rafick‐Pierre Sékaly · 2013 · Immunological Reviews
  39. New assays for monitoring residual HIV burden in effectively treated individuals
    Matthew C. Strain, Douglas D. Richman · 2013 · Current Opinion in HIV and AIDS
  40. CD4+T cells spontaneously producing human immunodeficiency virus type I in breast milk from women with or without antiretroviral drugs
    Diane Valéa, Édouard Tuaillon, Yassine Al Tabaa, François Rouet, Pierre‐Alain Rubbo, Nicolas Méda, Vincent Foulongne, Karine Bolloré, Nicolas Nagot, Philippe Van de Perre et al. · 2011 · Retrovirology
  41. Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation
    Sifei Xing, Shridhar Bhat, Neeta S. Shroff, Hao Zhang, Joseph A. Lopez, Joseph B. Margolick, Jun O. Liu, Robert F. Siliciano · 2011 · Journal of Antimicrobial Chemotherapy
  42. Kinetics of HIV-1 Latency Reversal Quantified on the Single-Cell Level Using a Novel Flow-Based Technique
    Glòria Martrus, Annika Niehrs, Rebecca Cornelis, Anne Rechtien, Wilfredo F. García-Beltrán, Marc Lütgehetmann, Christian Hoffmann, Marcus A. Altfeld · 2016 · Journal of Virology
  43. Modeling the Mechanisms by Which HIV-Associated Immunosuppression Influences HPV Persistence at the Oral Mucosa
    Meghna Verma, Samantha Erwin, Vida Abedi, Raquel Hontecillas, Stefan Hoops, Andrew J. Leber, Josep Bassaganya-Riera, Stanca M. Ciupe · 2017 · PLoS ONE
  44. Effect of the Latent Reservoir on the Evolution of HIV at the Within- and Between-Host Levels
    Hilje M. Doekes, Christophe Fraser, Katrina Lythgoe · 2017 · PLoS Computational Biology
  45. HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals
    Julia Sung, Shabnum Patel, Matthew L. Clohosey, Lauren Roesch, Tamara Tripic, JoAnn D. Kuruc, Nancie M. Archin, Patrick J. Hanley, Carolina Colli Cruz, Nilu P Goonetilleke et al. · 2018 · Molecular Therapy
  46. CD32 + and PD-1 + Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals
    Alessandra Noto, Francesco A. Procopio, Riddhima Banga, Madeleine Suffiotti, Jean-Marc Corpataux, Matthias L. Cavassini, Agostino Riva, Craig W. Fenwick, Raphaël Gottardo, Matthieu Perreau et al. · 2018 · Journal of Virology
  47. Benefits and limitations of humanized mice in HIV persistence studies
    Matthew D. Marsden · 2020 · Retrovirology
  48. The role of antigenic stimulation and cytotoxic T cell activity in regulating the long–term immunopathogenesis of HIV: mechanisms and clinical implications
    Christophe Frazer, Neil M. Ferguson, Frank de Wolf, Roy Malcolm Anderson · 2001 · Proceedings of the Royal Society B Biological Sciences
  49. Vpr Is Required for Efficient Nef Expression from Unintegrated Human Immunodeficiency Virus Type 1 DNA
    Betty Poon, Michael A. Chang, Irvin S. Y. Chen · 2007 · Journal of Virology
  50. Phylogenetics and Phyloanatomy of HIV/SIV Intra-Host Compartments and Reservoirs: The Key Role of the Central Nervous System
    Marco Salemi, Brittany Rife Magalis · 2015 · Current HIV Research
  51. Virus population dynamics, fitness variations and the control of viral disease: an update
    Esteban Domingo, Antonio Más, Eloísa Yuste, Nonia Pariente, Saleta Sierra, Mónica Gutiérrez‐Rivas, Luis Menéndez‐Arias · 2001 · Birkhäuser Basel eBooks
  52. Decay of HIV-1 DNA in Patients Receiving Suppressive Antiretroviral Therapy
    Jacques Izopet, G. Salama, Christophe Pasquier, Karine Sauné, Bruno Marchou, Patrice Massip, J. Puel · 1998 · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
  53. Efficacy of Low‐Dose Intermittent Subcutaneous Interleukin (IL)–2 in Antiviral Drug–Experienced Human Immunodeficiency Virus–Infected Persons with Detectable Virus Load: A Controlled Study of 3 IL‐2 Regimens with Antiviral Drug Therapy
    Giuseppe Tambussi, Silvia Ghezzi, Silvia Nozza, Giuliana Vallanti, Lorenzo Magenta, Monica Guffanti, Andrea Brambilla, Elisa Vicenzi, Paola Carrera, Sara Racca et al. · 2001 · The Journal of Infectious Diseases
  54. The multifaceted nature of HIV tissue reservoirs
    Riddhima Banga, Matthieu Perreau · 2024 · Current Opinion in HIV and AIDS
  55. Dendritic Cell-induced Activation of Latent HIV-1 Provirus in Actively Proliferating Primary T Lymphocytes
    Renée Marije van der Sluis, Thijs van Montfort, Georgios Pollakis, Rogier W. Sanders, Dave Speijer, Ben Berkhout, Rienk E. Jeeninga · 2013 · PLoS Pathogens
  56. Studies of retroviral infection in humanized mice
    Matthew D. Marsden, Jerome A. Zack · 2015 · Virology
  57. Plasma membrane signaling in HIV-1 infection
    Wasim Abbas, Georges Herbein · 2013 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  58. Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
    Matthew D. Marsden, Xiaomeng Wu, Sara M. Navab, Brian A. Loy, Adam J. Schrier, Brian A. DeChristopher, Akira Shimizu, Clayton Hardman, Stephen Ho, Christina M. Ramirez et al. · 2018 · Virology
  59. Factors that mold the nuclear landscape of HIV-1 integration
    Gregory J. Bedwell, Alan Engelman · 2020 · Nucleic Acids Research
  60. Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs
    Joseph E. Rittiner, Mohanapriya Cumaran, Sahil Malhotra, Boris Kantor · 2022 · Frontiers in Bioengineering and Biotechnology
  61. Impact of misclassified defective proviruses on HIV reservoir measurements
    Daniel B. Reeves, Christian Gaebler, Thiago Y. Oliveira, Michael J. Peluso, Joshua Tisdell Schiffer, Lillian B. Cohn, Steven G. Deeks, Michel C. Nussenzweig · 2023 · Nature Communications
  62. Influence of Peak Viral Load on the Extent of CD4+ T-Cell Depletion in Simian HIV Infection
    Miles P. Davenport, Lei Zhang, John W. Shiver, Danilo R. Casmiro, Ruy Miguel Ribeiro, Alan S. Perelson · 2006 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  63. Interactions between HIV ‐1 and Mucosal Cells in the Female Reproductive Tract
    Ruizhong Shen, Holly Elizabeth Richter, Phillip D. Smith · 2014 · American Journal of Reproductive Immunology
  64. Lessons in AIDS Vaccine Development Learned from Studies of Equine Infectious, Anemia Virus Infection and Immunity
    Jodi K. Craigo, Ronald C. Montelaro · 2013 · Viruses
  65. A novel method for determining the inhibitory potential of anti-HIV drugs
    Lin Shen, Seyed Alireza Rabi, Robert F. Siliciano · 2009 · Trends in Pharmacological Sciences
  66. Integration of Human Immunodeficiency Virus Type 1 in Untreated Infection Occurs Preferentially within Genes
    Hongbing Liu, Eugene C. Dow, Reetakshi Arora, Jason T. Kimata, Lara Bull–Otterson, Roberto C. Arduino, Andrew P. Rice · 2006 · Journal of Virology
  67. Identification of Nevirapine‐Resistant HIV‐1 in the Latent Reservoir after Single‐Dose Nevirapine to Prevent Mother‐to‐Child Transmission of HIV‐1
    Megan Wind‐Rotolo, Christine M. Durand, Lisa Marie Cranmer, Alison P. Reid, Neil Alexander Martinson, Meg C. Doherty, Benjamin L. Jilek, Joseph Kagaayi, Allan Kizza, Visva Pillay et al. · 2009 · The Journal of Infectious Diseases
  68. Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1
    Julie Bestman‐Smith, Pierrette Gourde, André Désormeaux, Michel J. Tremblay, Michel G. Bergeron · 2000 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  69. Markers of Lymphocyte Homing Distinguish CD4 T Cell Subsets That Turn Over in Response to HIV-1 Infection in Humans
    Richard L. Hengel, Bonnie M Jones, M Susan Kennedy, Marjorie Hubbard, J. Steven McDougal · 1999 · The Journal of Immunology
  70. Broad‐spectrum virus reduction in red cell concentrates using INACTINE™ PEN110 chemistry
    Aris Lazo, Jodie Tassello, V. Jayarama, Åsa Öhagen, Veronica Gibaja, Ed Kramer, A. Marmorato, D. Billia‐Shaveet, Andrei A. Purmal, Fred Brown et al. · 2002 · Vox Sanguinis
  71. HIV/AIDS eradication
    Matthew D. Marsden, Jerome A. Zack · 2013 · Bioorganic & Medicinal Chemistry Letters
  72. Rapid Turnover of 2-LTR HIV-1 DNA during Early Stage of Highly Active Antiretroviral Therapy
    Weijun Zhu, Yanmei Jiao, Rongyue Lei, Wei Hua, Rui Wang, Yunxia Ji, Zhiying Liu, Feili Wei, Tong Zhang, Xuanlin Shi et al. · 2011 · PLoS ONE
  73. Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies
    Timothy J. Henrich, Steven G. Deeks, Satish K. Pillai · 2017 · The Journal of Infectious Diseases
  74. Despite early antiretroviral therapy effector memory and follicular helper CD4 T cells are major reservoirs in visceral lymphoid tissues of SIV-infected macaques
    Henintsoa Rabezanahary, Félicien Moukambi, David Palesch, Julien A. Clain, Gina Racine, Guadalupe Andreani, Ghita Benmadid-Laktout, Ouafa Zghidi‐Abouzid, Calayselvy Soundaramourty, Cecile L. Tremblay et al. · 2019 · Mucosal Immunology
  75. HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo
    Andrew E. Timmons, Emily J. Fray, Mithra R. Kumar, Fengting Wu, Weiwei Dai, C. Korin Bullen, Peggy Kim, Carrie A. Hetzel, Chao Yang, Subul A. Beg et al. · 2020 · Proceedings of the National Academy of Sciences
  76. Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients
    Isabella Bon, Davide Gibellini, Marco Borderi, Federica Alessandrini, Francesca Vitone, Pasqua Schiavone, Maria Carla Re · 2007 · Journal of Clinical Virology
  77. A unified concept of HIV latency
    Omar Bagasra · 2006 · Expert Opinion on Biological Therapy
  78. Continued evolution of HIV-1 circulating in blood monocytes with antiretroviral therapy: genetic analysis of HIV-1 in monocytes and CD4+ T cells of patients with discontinued therapy
    Nick Llewellyn, Rafael Zioni, Haiying Zhu, Thomas Andrus, Younong Xu, Lawrence Corey, Tuofu Zhu · 2006 · Journal of Leukocyte Biology
  79. Memory CD8 + T cells in HIV infection
    Andrew James McMichael, Graham Stuart Ogg, Jamie Wilson, Margaret F. C. Callan, Sophie Hambleton, Victor Appay, Tony Kelleher, Sarah L. Rowland-Jones · 2000 · Philosophical Transactions of the Royal Society B Biological Sciences
  80. In Vitro Reactivation of Human Immunodeficiency Virus 1 from Latently Infected, Resting CD4+T Cells after Bacterial Stimulation
    Hiroyuki Moriuchi, Masako Moriuchi, Stephanie B. Mizell, Linda A. Ehler, Anthony S. Fauci · 2000 · The Journal of Infectious Diseases
  81. Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia
    Mario Clerici, Elena Maria Seminari, Fredy Suter, Francesco Castelli, Angelo Pan, Mara Biasin, Fulvia Colombo, Daria Trabattoni, Franco Maggiolo, Giampiero Carosi et al. · 2000 · AIDS
  82. Molecular Understanding of HIV-1 Latency
    Wasim Abbas, Georges Herbein · 2012 · Advances in Virology
  83. Therapeutic vaccines and immunological intervention in HIV infection
    Giuseppe Pantaleo, Yves Lévy · 2016 · Current Opinion in HIV and AIDS
  84. In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies
    Christopher C. Nixon, Maud Mavigner, Guido Silvestri, J. Víctor García · 2017 · The Journal of Infectious Diseases
  85. Defective Virus Drives Human Immunodeficiency Virus Infection, Persistence, and Pathogenesis
    Diana Finzi, Susan F. Plaeger, Carl W. Dieffenbach · 2006 · Clinical and Vaccine Immunology
  86. Betulinic Acid Derivatives That Target gp120 and Inhibit Multiple Genetic Subtypes of Human Immunodeficiency Virus Type 1
    Weihong Lai, Li Huang, Phong Ho, Zhijun Li, David C. Montefiori, Chin‐Ho Chen · 2007 · Antimicrobial Agents and Chemotherapy
  87. Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+T CellsIn Vitro
    Jennifer M. Zerbato, Erik Serrao, Gina M. Lenzi, Baek Kim, Zandrea Ambrose, Simon C. Watkins, Alan Engelman, Nicolas Sluis‐Cremer · 2016 · Journal of Virology
  88. Mathematical Models of HIV Latency
    Alison L. Hill · 2017 · Current topics in microbiology and immunology
  89. Persistence of Human Immunodeficiency Virus (HIV) Type 1 DNA in Peripheral Blood Despite Prolonged Suppression of Plasma HIV‐1 RNA in Children
    Akihiko Saitoh, Karen Hsia, Terence Fenton, Christine A. Powell, Cindy Christopherson, Courtney Vail Fletcher, Stuart E. Starr, Stephen A. Spector · 2002 · The Journal of Infectious Diseases
  90. Cysteine, glutathione (GSH) and zinc and copper ions together are effective, natural, intracellular inhibitors of (AIDS) viruses
    J. E. Sprietsma · 1999 · Medical Hypotheses
  91. TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen
    Sanjay UC Sankatsing, Gerrit Jan Weverling, Monika Peeters, Gerben A.E. van 't Klooster, Б М Груздев, Aza Gasanovna Rakhmanova, Sven A. Danner, Suzanne Jurriaans, Jan M. Prins, Joep M. A. Lange · 2003 · AIDS
  92. Immunologic Profile of Highly Exposed Yet HIV Type 1-Seronegative Men
    Otto O. Yang, W. John Boscardin, Jose L. Matud, Mary Ann Hausner, Lance E. Hultin, Patricia M. Hultin, Roger Shih, John Ferbas, Frederick P. Siegal, Michael Shodell et al. · 2002 · AIDS Research and Human Retroviruses
  93. Protein Kinase Cθ Is a Specific Target for Inhibition of the HIV Type 1 Replication in CD4+ T Lymphocytes
    María Rosa López‐Huertas, Elena Mateos, Gema Díaz‐Gil, Francisco Gómez‐Esquer, María Sánchez del Cojo, José Alcamı́, Mayte Coiras · 2011 · Journal of Biological Chemistry
  94. Triplex-forming MicroRNAs Form Stable Complexes With HIV-1 Provirus and Inhibit its Replication
    Mazhar A. Kanak, Mohamed Alseiari, Prathap Balasubramanian, Krishna C. Addanki, Mayank Aggarwal, Samina Noorali, Azima Kalsum, Kuha Mahalingam, Gene Pace, Nicholas Panasik et al. · 2010 · Applied immunohistochemistry & molecular morphology
  95. Pharmaceutical approaches to eradication of persistent HIV infection
    Mary Catherine Bowman, Nancie M. Archin, David M. Margolis · 2009 · Expert Reviews in Molecular Medicine
  96. Cell-to-cell transfer of HIV infection: implications for HIV viral persistence
    Cecilia Theresa Costiniuk, Mohammad-Ali Jenabian · 2014 · Journal of General Virology
  97. Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques
    Anthony M. Cadena, John D. Ventura, Peter Abbink, Erica N. Borducchi, Hubert Tuyishime, Noe B. Mercado, Victoria E. K. Walker-Sperling, Mazuba Siamatu, Po-Ting Liu, Abishek Chandrashekar et al. · 2021 · Nature Communications
  98. HIV-1–specific CTLs effectively suppress replication of HIV-1 in HIV-1–infected macrophages
    Mamoru Fujiwara, Masafumi Takiguchi · 2007 · Blood
  99. CD4+ NK cells can be productively infected with HIV, leading to downregulation of CD4 expression and changes in function
    Helene B. Bernstein, Guangwu Wang, Mary C. Plasterer, Jerome A. Zack, Parthasarathy Ramasastry, Shannon M. Mumenthaler, Christina M. Ramirez · 2009 · Virology
  100. Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients
    Marianne Burgard, Faroudy Boufassa, Jean‐Paul Viard, Isabelle Garrigue, Annick Ruffault, Jacques Izopet, Astrid Vabret, Diane Descamps, Philippe Colson, Jean‐Marie Seigneurin et al. · 2009 · AIDS